| 1 |
Woodruff MF, Anderson NA. Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocytic serum on the survival of skin homografts in rats[J]. Nature, 1963, 200：702.
|
| 2 |
Starzl TE, Marchioro TL, Porter KA, et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation[J]. Surg Gynecol Obstet, 1967, 124(2)：301-308.
|
| 3 |
Anwar IJ, DeLaura IF, Gao Q, et al. Harnessing the B cell response in kidney transplantation-current state and future directions[J]. Front Immunol, 2022，13：903068.
|
| 4 |
Liao T, Shi X, Han F, et al. Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection[J]. J Heart Lung Transplant, 2024, 43(4)：652-662.
|
| 5 |
Han F, Shi X, Liao T, et al. Bruton′s tyrosine kinase ablation inhibits B cell responses and antibody production for the prevention of chronic rejection in cardiac transplantation[J]. Clin Immunol, 2024, 261：109941.
|
| 6 |
Liu R, Shi X, Zeng W, et al. Novel janus kinase 3 inhibitor ritlecitinib suppresses T and B cell responses to prevent acute cardiac allograft rejection in mice [J]. Clin Immunol, 2025，273：110445.
|
| 7 |
Xia R, Shi X, Zhang H, et al. IL-6/IL-6R signaling blockade alleviates chronic allograft rejection by modulating germinal center B cells and allograft inflammation in murine cardiac transplantation[J]. J Inflamm Res, 2025, 18：9145-9158.
|
| 8 |
Chen YB, Elias N, Heher E, et al. Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure[J]. Blood, 2019, 134(2)：211-215.
|
| 9 |
El JN, DeFor T, Adamusiak AM, et al. Hematopoietic cell and solid organ transplantation in the same patient: long-term experience at the University of Minnesota[J]. Transplant Cell Ther, 2021，27(1)：81-87.
|
| 10 |
Bertaina A, Grimm PC, Weinberg K, et al. Sequential stem cell- kidney transplantation in schimke immuno-osseous dysplasia[J]. N Engl J Med, 2022, 386(24)：2295-2302.
|
| 11 |
Busque S, Scandling JD, Lowsky R, et al. Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal[J]. Sci Transl Med, 2020，12(528)：eaax8863.
|
| 12 |
Pan GH, Chen Z, Xu L, et al. Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study[J]. Oncotarget, 2016, 7(11)：12089-12101.
|
| 13 |
Zeng J, Ma M, Jiang X, et al. Enzymatic conversion of blood group B kidney prevents hyperacute antibody-mediated injuries in ABO- incompatible transplantation[J]. Nat Commun, 2025, 16(1)：1506.
|
| 14 |
Zeng J, Ma M, Tao Z, et al. Enzyme-converted O kidneys allow ABO-incompatible transplantation without hyperacute rejection in a human decedent model[J]. Nat Biomed Eng, 2025. [Epub ahead of print]
|
| 15 |
de Weerd AE, Roelen DL, van de Wetering J, et al. Imlifidase desensitization in HLA-incompatible kidney transplantation: finding the sweet spot[J]. Transplantation, 2024, 108(2)：335-345.
|
| 16 |
Yuzefovych Y, Valdivia E, Rong S, et al. Genetic engineering of the kidney to permanently silence MHC transcripts during ex vivo organ perfusion[J]. Front Immunol, 2020, 11：265.
|
| 17 |
Manon J, Evrard R, Maistriaux L, et al. HLA awareness in tissue decellularization: a paradigm shift for enhanced biocompatibility, studied on the model of the human fascia lata graft[J]. Biomaterials, 2025, 312：122741.
|
| 18 |
Alexander SI, Smith N, Hu M, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant[J]. N Engl J Med, 2008, 358(4)：369-374.
|
| 19 |
Norris S, Lawler M, McCann S, et al. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance[J]. Hepatology, 1997, 26(4)：848-852.
|